| Bioactivity | (Neurodegenerative diseases) NDs-IN-1 (Compound 3g) inhibits the activities of key enzymes such as hBACE-1, hAChE and hMAO-B. NDs-IN-1 is a novel non-covalent multi-target inhibitor. NDs-IN-1 is mainly used in the study of neurodegenerative diseases[1]. |
| CAS | 3033806-97-9 |
| Formula | C20H18N2O2 |
| Molar Mass | 318.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mousavi H et al. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases. ACS Chem Neurosci. 2024 May 1;15(9):1828-1881. |
NDs-IN-1
CAS: 3033806-97-9 F: C20H18N2O2 W: 318.37
(Neurodegenerative diseases) NDs-IN-1 (Compound 3g) inhibits the activities of key enzymes such as hBACE-1, hAChE and hM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.